World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
88
Citations
24737
World Ranking
1181
National Ranking
624

Medicine

D-Index
88
Citations
24921
World Ranking
13283
National Ranking
6763

Overview

Allan D. Kirk is affiliated with Duke University in the United States. Their research primarily falls within the field of Medicine, with a focus on Surgery, Immunology, and Transplantation. The body of work includes significant contributions to areas such as Renal Transplantation Outcomes and Treatments, Xenotransplantation and immune response, and T-cell and B-cell Immunology.

The scientist's recent papers demonstrate active engagement with transplant immunology and surgical outcomes. Notable publications include:

  • Roadmap for Transforming Preoperative Assessment to Preoperative Optimization, 2020, Anesthesia & Analgesia
  • A comparison of deprivation indices and application to transplant populations, 2023, American Journal of Transplantation
  • The anti-CD40L monoclonal antibody AT-1501 promotes islet and kidney allograft survival and function in nonhuman primates, 2023, Science Translational Medicine
  • Kidney transplantation using alemtuzumab, belatacept, and sirolimus: Five-year follow-up, 2020, American Journal of Transplantation
  • Optimization of de novo belatacept-based immunosuppression administered to renal transplant recipients, 2020, American Journal of Transplantation

Frequent coauthors collaborating with Allan D. Kirk include:

  • Brian I. Shaw
  • Eric A. Elster
  • Lisa M. McElroy
  • Seth Schobel
  • Linda Stempora

The scientist publishes regularly in several venues, with a concentration of work appearing in the following journals:

  • American Journal of Transplantation
  • Annals of Surgery Open
  • Annals of Surgery
  • Surgery
  • The Journal of Trauma: Injury, Infection, and Critical Care

The main topics covered in their research include:

  • Renal Transplantation Outcomes and Treatments
  • Xenotransplantation and immune response
  • T-cell and B-cell Immunology
  • Organ Transplantation Techniques and Outcomes
  • Immune Cell Function and Interaction
  • Organ Donation and Transplantation
  • Cardiac, Anesthesia and Surgical Outcomes

Subfields of their study encompass Surgery, Immunology, Transplantation, Pulmonary and Respiratory Medicine, and Public Health, Environmental and Occupational Health, reflecting a multidisciplinary approach within medical research.

Best Publications

  • CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates

    Allan D. Kirk;David M. Harlan;Nicholas N. Armstrong;Thomas A. Davis

  • Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates.

    Allan D. Kirk;Allan D. Kirk;Allan D. Kirk;Linda C. Burkly;D. Scott Batty;Roxanne E. Baumgartner

  • Identification of a B cell signature associated with renal transplant tolerance in humans

    Kenneth A. Newell;Adam Asare;Allan D. Kirk;Trang D. Gisler

  • The Banff 2007 working classification of skin-containing composite tissue allograft pathology.

    L. C. Cendales;J. Kanitakis;S. Schneeberger;S. Schneeberger;C. Burns

  • Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154

    Norma S. Kenyon;Maria Chatzipetrou;Michele Masetti;Alessandra Ranuncoli

  • Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion.

    Jonathan P. Pearl;Jeremy Parris;Douglas A. Hale;Douglas A. Hale;Steven C. Hoffmann

  • Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H).

    Allan D. Kirk;Douglas A. Hale;Roslyn B. Mannon;David E. Kleiner

  • Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes.

    Steven C. Hoffmann;Eran M. Stanley;E. Darrin Cox;Nancy Craighead

  • ETHNICITY GREATLY INFLUENCES CYTOKINE GENE POLYMORPHISM DISTRIBUTION

    Steven C. Hoffmann;Eran M. Stanley;E. Darrin Cox;Barbara S. DiMercurio

  • Treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation

    Ravi S. Chari;Bradley H. Collins;John C. Magee;J. Michael Dimaio

  • The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts

    Scott K. Pruitt;Allan D. Kirk;R. Randal Bollinger;Henry C. Marsh

  • Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154.

    Norma S. Kenyon;Luis A. Fernandez;Roger Lehmann;Michele Masetti

  • Donor leukocyte infusions in acute lymphocytic leukemia.

    Robert H Collins;S. Goldstein;S. Giralt;J. Levine

  • CD40 ligand (CD154) triggers a short-term CD4(+) T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis.

    Patrick J. Blair;James L. Riley;David M. Harlan;Ryo Abe

  • Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates

    Tim A Weaver;Ali H Charafeddine;Ali H Charafeddine;Avinash Agarwal;Alexandra P Turner

  • Urinary Chemokines CXCL9 and CXCL10 Are Noninvasive Markers of Renal Allograft Rejection and BK Viral Infection

    Jennifer A. Jackson;Eugenia J. Kim;Beth Begley;Jennifer Cheeseman

  • Dissociation of depletional induction and posttransplant lymphoproliferative disease in kidney recipients treated with alemtuzumab.

    A. D. Kirk;W. S. Cherikh;M. Ring;G. Burke

  • Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6.

    Cox Ed;Hoffmann Sc;DiMercurio Bs;Wesley Ra

  • Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis

    Marinos C. Dalakas;Goran Rakocevic;Jens Schmidt;Mohammad Salajegheh

  • The role of donor-specific HLA alloantibodies in liver transplantation.

    J.G. O'Leary;A.J. Demetris;L.S. Friedman;Howard Gebel

Frequent Co-Authors

Christian P. Larsen
Christian P. Larsen Emory University
Stuart J. Knechtle
Stuart J. Knechtle Duke University
David E. Kleiner
David E. Kleiner National Institutes of Health
Mandy L. Ford
Mandy L. Ford Emory University
Linda C. Burkly
Linda C. Burkly Biogen (United States)
Thomas C. Pearson
Thomas C. Pearson Emory University
Hans W. Sollinger
Hans W. Sollinger University of Wisconsin–Madison
Keith A. Reimann
Keith A. Reimann Harvard Medical School
John D. Pirsch
John D. Pirsch University of Wisconsin–Madison
Bruce R. Blazar
Bruce R. Blazar University of Minnesota

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology opens the door to various healthcare and research careers, many of which can be enhanced through specialized online programs. For those interested in psychiatric nursing, exploring the best pmhnp programs offers insight into top-tier education combined with strong clinical placements, crucial for hands-on experience.

Cost is always a factor, and finding affordable pmhnp programs can make advanced nursing education more accessible without compromising quality. This is especially important for working professionals aiming to balance study and work.

Understanding the salary outlook is key for career planning. Knowing how much do dnp nurses make helps gauge the return on investment for a Doctor of Nursing Practice degree and can guide decisions about location and specialty.

For nurses contemplating a shift in focus, certification, such as acute care np certification, provides a pathway to new roles in critical care environments. These credentials broaden career options and enhance expertise in patient management.

Best Scientists Citing Allan D. Kirk

Trending Scientists

Recently Published Articles